Cardiac involvement in thalassemia intermedia: a multicenter study
Top Cited Papers
Open Access
- 1 June 2001
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 97 (11), 3411-3416
- https://doi.org/10.1182/blood.v97.11.3411
Abstract
Cardiac complications in 110 patients (mean age, 32.5 ± 11.4 years) with thalassemia intermedia (TI) were studied. Sixty-seven (60.9%) of them had not been transfused or were minimally transfused (group A). The rest had started transfusions after the age of 5 years (mean, 15.1 ± 10.1 years), initially on demand and later more frequently (group B). Overall mean hemoglobin and ferritin levels were 9.1 ± 1.1 g/dL and 1657 ± 1477 ng/mL, respectively. Seventy-six healthy controls were also studied. The investigation included thorough history taking, clinical examination, electrocardiography, chest radiograph, and full resting echocardiography. Of 110 patients, 6 (5.4%) had congestive heart failure (CHF), and 9 (8.1%) had a history of acute pericarditis. Echocardiography showed pericardial thickening, with or without effusion, in 34.5% of the patients. Valvular involvement included leaflet thickening (48.1%), endocardial calcification (20.9%), and left-sided valve regurgitation (aortic, 15.4%; mitral, 47.2%). All patients had normal left ventricular contractility (fractional shortening, 0.43 ± 0.05), and high cardiac output (CO; 9.34 ± 2.28 L/min). Pulmonary hypertension (PHT), defined as Doppler peak systolic tricuspid gradient greater than 30 mm Hg, developed in 65 patients (59.1%). PHT correlated positively with age and CO and did not differ significantly between groups. Cardiac catheterization in the 6 patients with CHF revealed severe PHT, increased pulmonary resistance (PVR), and normal capillary wedge pressure. It was concluded that in patients with TI, the heart is primarily affected by PHT, which is the leading cause of CHF. High CO resulting from chronic tissue hypoxia and increased PVR are the main contributing factors. Doppler tricuspid gradient measurement should be considered, in addition to other factors, when determining the value of transfusion therapy for patients with TI.Keywords
This publication has 37 references indexed in Scilit:
- Left ventricular hypertrophy and geometry in a population sample of elderly malesEuropean Heart Journal, 1996
- A practical guide to assessment of ventricular diastolic function using doppler echocardiographyJournal of the American College of Cardiology, 1996
- Pulmonary Hypertension and Right Heart Failure in Patients With β-Thalassemia IntermediaSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1995
- Recommendations for Quantitation of the Left Ventricle by Two-Dimensional EchocardiographyJournal of the American Society of Echocardiography, 1989
- SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJORThe Lancet, 1989
- Reconsideration of echocardiographic standards for mitral valve prolapse: Lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormalityJournal of the American College of Cardiology, 1988
- Color Doppler assessment of mitral regurgitation with orthogonal planes.Circulation, 1987
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986
- LONGITUDINAL STUDY OF CARDIAC FUNCTION IN THALASSEMIA MAJOR *Annals of the New York Academy of Sciences, 1980
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978